Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

Fitting Linear Mixed-Effects Models Using lme4

Bates, D., Mächler, M., Bolker, B., & Walker, S. (2015) · Journal of Statistical Software · doi:10.18637/jss.v067.i01 · Cited by 86,835

Modern Applied Statistics with S

Venables, W. N., & Ripley, B. D. (2002) · Statisctics and computing/Statistics and computing · doi:10.1007/978-0-387-21706-2 · Cited by 25,941

pROC: an open-source package for R and S+ to analyze and compare ROC curves

Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-77 · Cited by 13,697

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791

Fitting Linear Mixed-Effects Models Using lme4Preprint

Bates, D. M., Maechler, M., Bolker, B. M., & Walker, S. (2014) · arXiv (Cornell University) · doi:10.3929/ethz-b-000105397 · Cited by 9,435

Histological grading and staging of chronic hepatitis.

Ishak, K., Baptista, A., Bianchi, L., Callea, F., Groote, J. D., Gudat, F., Denk, H., Desmet, V., Korb, G., Macsween, R. N., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,290

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Chalasani, N., Younossi, Z. M., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K. J., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,854

Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients With Chronic Hepatitis C

Bédossa, P. (1994) · Hepatology · doi:10.1002/hep.1840200104 · Cited by 2,189

AASLD guidelines for treatment of chronic hepatitis B

Terrault, N. A., Bzowej, N. H., Chang, K., Hwang, J. P., Jonas, M. M., & Murad, M. H. (2015) · Hepatology · doi:10.1002/hep.28156 · Cited by 2,002

Noninvasive monitoring of liver fat during treatment with GLP‐1 analogues and SGLT‐2 inhibitors in a real‐world setting

Mittag‐Roussou, V., Wagenpfeil, S., Lammert, F., & Stokes, C. S. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.131 · Cited by 17

Liver and Nonliver‐Related Outcomes at 2 Years Are Not Influenced by the Results of the FIB‐4 Test and Liver Elastography in a Real‐Life Cohort of Patients with Type 2 Diabetes

Grgurević, I., Salkic, N. N., Mustapić, S., Bokun, T., Podrug, K., Marušić, S., Rahelić, D., Matić, T., Škurla, V., & Mikolašević, I. (2021) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2021/5582813 · Cited by 16

Improved Ultrasound Attenuation Measurement Method for the Non-invasive Evaluation of Hepatic Steatosis Using FibroScan

Audière, S., Labourdette, A., Miette, V., Fournier, C., Ternifi, R., Boussida, S., Pouletaut, P., Charleux, F., Bensamoun, S. F., Harrison, S. A., et al. (2021) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2021.07.007 · Cited by 16

Relationship between controlled attenuated parameter and magnetic resonance imaging–proton density fat fraction for evaluating hepatic steatosis in patients with NAFLD

An, Z., Liu, Q., Zeng, W., Wang, Y., Zhang, Q., Pei, H., Xin, X., Yang, S., Fang, L., Zhao, Y., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.1948 · Cited by 16

Comparison of Serum Ketone Levels and Cardiometabolic Efficacy of Dapagliflozin versus Sitagliptin among Insulin-Treated Chinese Patients with Type 2 Diabetes Mellitus

Lee, C., Wu, M., Lui, D. T. W., Chan, D. S.-H., Fong, C. H.-Y., Shiu, S. W. M., Wong, Y., Lee, A. C., Lam, J. K. Y., Woo, Y. C., et al. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0319 · Cited by 18

Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes

Alfadda, A. A., Sherbeeni, S. M., Alqutub, A. N., Aldosary, A. S., Al‐Daghri, N. M., Taylor-Robinson, S. D., Alqahtani, S. A., Gul, R., & Almaghamsi, A. M. (2022) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_73_22 · Cited by 19

Nonalcoholic fatty liver disease and steatohepatitis in people living with HIV

Squillace, N., Soria, A., Bozzi, G., Gori, A., & Bandera, A. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1614913 · Cited by 16

Functional Microbial Responses to Alcohol Abstinence in Patients With Alcohol Use Disorder

Gao, B., Emami, A., Zhou, R., Lang, S., Duan, Y., Wang, Y., Jiang, L., Loomba, R. S., Brenner, D. A., Stärkel, P., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00370 · Cited by 16

In vivo Ultrafast Quantitative Ultrasound and Shear Wave Elastography Imaging on Farm-Raised Duck Livers during Force Feeding

Gesnik, M., Bhatt, M., Cardinal, M. R., Destrempes, F., Allard, L., Nguyen, B., Alquier, T., Giroux, J., Tang, A., & Cloutier, G. (2020) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2020.03.005 · Cited by 16

Effects of obesity reduction on transient elastography–based parameters in pediatric non-alcoholic fatty liver disease

Isoura, Y., Cho, Y., Fujimoto, H., Hamazaki, T., & Tokuhara, D. (2020) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2020.08.005 · Cited by 16

Baseline elevated serum angiopoietin-2 predicts long-term non-regression of liver fibrosis after direct-acting antiviral therapy for hepatitis C

Kawagishi, N., Suda, G., Kimura, M., Maehara, O., Yamada, R., Tokuchi, Y., Kubo, A., Kitagataya, T., Shigesawa, T., Suzuki, K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-88632-7 · Cited by 16

Collaboration, Not Competition: The Role of Magnetic Resonance, Transient Elastography, and Liver Biopsy in the Diagnosis of Nonalcoholic Fatty Liver Disease

Karlas, T., Petroff, D., & Wiegand, J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.12.013 · Cited by 16

Prevalence of MASLD, Met-ALD, and ALD and Associated Fibrosis Among US Adults

Paik, J. M., Hobbs, K., Gupta, A., Alkalbani, R., Reyes, M. A., & Younossi, Z. M. (2025) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002202 · Cited by 15

Sex Differences in MASLD After Age 50: Presentation, Diagnosis, and Clinical Implications

Milani, I., Parrotta, M. E., Colangeli, L., Chinucci, M., Palleschi, S., Rossi, B., Sbraccia, P., Mantovani, A., Leonetti, F., Guglielmi, V., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13092292 · Cited by 15

Binge drinking, metabolic dysfunction, and the spectrum of steatotic liver disease in the USA: a cross-sectional and longitudinal analysis

Younossi, Z. M., Krag, A. A., Zelber‐Sagi, S., Kalligeros, M., Arrese, M., Díaz, L. A., Arab, J. P., Singal, A. K., Pessoa, M. G., Wong, R. J., et al. (2026) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(25)00376-0 · Cited by 15

The Prevalence and Determinants of NAFLD and MAFLD and Their Severity in the VA Primary Care Setting

Thrift, A. P., Nguyen, T. H.-A., Pham, C., Balakrishnan, M., Kanwal, F., Loomba, R. S., Duong, H. T., Ramsey, D. J., & El‐Serag, H. B. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.05.046 · Cited by 15

Prevalence of non-alcoholic fatty liver disease in a multicentre cohort of people living with HIV in Spain.

Navarro, J., Curran, A., Raventós, B., Garcia, J. N., Suanzes, P., Descalzo, V., Álvarez, P., Espinosa, N., Montes, M., Suárez‐García, I., et al. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.01.028 · Cited by 15

Hepatitis C virus eradication by direct‐acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low‐density lipoprotein cholesterolemia without an increase in body weight

Tokuchi, Y., Suda, G., Kawagishi, N., Ohara, M., Kohya, R., Sasaki, T., Yoda, T., Maehara, O., Ohnishi, S., Kubo, A., et al. (2023) · Hepatology Research · doi:10.1111/hepr.13899 · Cited by 15

Transient elastography with controlled attenuation parameter versus two-dimensional shear wave elastography with attenuation imaging for the evaluation of hepatic steatosis and fibrosis in NAFLD

Seo, J. W., Kim, Y. R., Jang, J. K., Kim, S. Y., Cho, Y. Y., Lee, E. S., & Lee, D. H. (2023) · ULTRASONOGRAPHY · doi:10.14366/usg.22212 · Cited by 15

Diagnosis and assessment of disease severity in patients with nonalcoholic fatty liver disease

Li, J., Delamarre, A., Wong, V. W., & de Lédinghen, V. (2023) · United European Gastroenterology Journal · doi:10.1002/ueg2.12491 · Cited by 15

Obesity and Metabolic Dysfunction-associated Fatty Liver Disease: Understanding the Intricate Link

Vulchi, J., Suryadevara, V., Mohan, P., Kamalanathan, S., Sahoo, J., Naik, D., & Selvarajan, S. (2023) · Journal of Translational Gastroenterology · doi:10.14218/jtg.2023.00043 · Cited by 18

Association between frailty and hepatic fibrosis in NAFLD among middle-aged and older adults: results from NHANES 2017–2020

Atabieke, F., Li, X., Aierken, A., Li, J., Zhang, Y., Aizezi, Y., Gao, H., & Zhang, Z.-Q. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1330221 · Cited by 15

Metabolic dysfunction-associated steatotic liver disease-related hepatic fibrosis increases risk of insulin resistance, type 2 diabetes, and chronic kidney disease

Zhang, W., Song, W. J., Chen, W., Pan, Z., Zhang, J., Fan, L., & Li, J. (2024) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002767 · Cited by 18

Dynamic change of metabolic dysfunction-associated steatotic liver disease in patients with hepatitis C virus infection after achieving sustained virologic response with direct-acting antivirals

Liu, C., Chang, Y., Fang, Y., Cheng, P., Chen, C.-Y., Kao, W., Lin, C., Yang, S., Shih, Y., Peng, C., et al. (2024) · Journal of Gastroenterology · doi:10.1007/s00535-024-02101-2 · Cited by 15

The mediating role of insulin resistance in the association between inflammatory score and MAFLD: NHANES 2017–2018

Chen, Y., & Zhao, X. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.70035 · Cited by 15

Activation of intestinal endogenous retroviruses by alcohol exacerbates liver disease

Cabré, N., Fondevila, M. F., Wei, W., Yamazaki, T., Tonetti, F. R., Eguileor, Á., Garcia‐Carbonell, R., Meijnikman, A. S., Miyamoto, Y., Mayo, S. L., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci188541 · Cited by 15

Hepatic steatosis and patients with inflammatory bowel disease: when transient elastography makes the difference

Arieira, C., Monteiro, S., Xavier, S. A., de Castro, F. D., Magalhães, J. T., Moreira, M. J., Marinho, C. M. M., & Cotter, J. B. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001319 · Cited by 15

Usefulness of Controlled Attenuation Parameter in Detecting and Monitoring Hepatic Steatosis with MRI-PDFF as Reference

Wang, J., Ou, H., Yen, Y., Chen, C., & Lu, S. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05883-1 · Cited by 15

Controlled attenuation parameter by vibration‐controlled transient elastography for steatosis assessment in members of the public undergoing regular health checkups with reference to magnetic resonance imaging‐based proton density fat fraction

Zeng, Q., Song, Z., Zhao, Y., Wu, J., Wang, L., Ye, H., Wang, Y., Wu, T., Yuan, S., & Yuan, H. (2019) · Hepatology Research · doi:10.1111/hepr.13481 · Cited by 15

How Good Are Controlled Attenuation Parameter Scores from Fibroscan to Assess Steatosis, NASH, and Fibrosis?

Trowell, J., Alukal, J. J., Zhang, T., Liu, L., Maheshwari, A., Yoo, H. Y., & Thuluvath, P. J. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06269-4 · Cited by 15

Applicability and Results of Liver Stiffness Measurement and Controlled Attenuation Parameter Using XL Probe for Metabolic-Associated Fatty Liver Disease in Candidates to Bariatric Surgery. A Single-Center Observational Study

Wan, T., Köhn, N., Kröll, D., & Berzigotti, A. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04971-w · Cited by 15

Defining values for controlled attenuation parameter and liver stiffness in youth without liver disease

Ramírez‐Vélez, R., García‐Hermoso, A., Correa‐Rodríguez, M., & Izquierdo, M. (2021) · Pediatric Research · doi:10.1038/s41390-021-01441-6 · Cited by 15

Diagnostic Performance of 2-D Shear-Wave Elastography with Propagation Maps and Attenuation Imaging in Patients with Non-Alcoholic Fatty Liver Disease

Podrug, K., Sporea, I., Lupușoru, R., Paštrović, F., Mustapić, S., Bâldea, V., Božin, T., Bokun, T., Salkic, N. N., Șirli, R., et al. (2021) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2021.03.025 · Cited by 15

The Association between Vitamin D and Nonalcoholic Fatty Liver Disease Assessed by Controlled Attenuation Parameter

Heo, N. J., Park, H. E., Yoon, J. W., Kwak, M., Yang, J. I., Chung, S. J., Yim, J. Y., & Chung, G. E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122611 · Cited by 15

Hepatic steatosis leads to overestimation of liver stiffness measurement in both chronic hepatitis B and metabolic-associated fatty liver disease patients

Liu, J., Ma, Y., Han, P., Wang, J., Liu, Y., Shi, R. F., & Li, J. (2022) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2022.101957 · Cited by 15

Prospective study comparing hepatic steatosis assessment by magnetic resonance imaging and four ultrasound methods in 105 successive patients

Collin, R., Magnin, B., Gaillard, C., Nicolas, C., Abergel, A., & Buchard, B. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i22.3548 · Cited by 16

Imaging-Based Assessment of Steatosis, Inflammation and Fibrosis in NAFLD

Hardy, T., & McPherson, S. (2017) · Current Hepatology Reports · doi:10.1007/s11901-017-0368-4 · Cited by 15

Point Shear Wave Elastography for Non-invasive Assessment of Liver Fibrosis in Patients with Viral Hepatitis

Bucsics, T., Grasl, B., Ferlitsch, A., Schwabl, P., Mandorfer, M., Zinober, K., Stern, R., Chromy, D., Scheiner, B., Sieghart, W., et al. (2018) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2018.07.031 · Cited by 15

Transient Elastography and Controlled Attenuation Parameter (CAP) in the Assessment of Liver Steatosis in Severe Adult Growth Hormone Deficiency

Carvalho-Furtado, A. C. L., Carvalho-Louro, D. M., Regattieri, N. A. T., Rodrigues, M. P., Montenegro, M. L. R. N., Ferro, A. M., Pirangi, P. S., & Naves, L. A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00364 · Cited by 15

Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV ‐monoinfected patients

Sebastiani, G., Cocciolillo, S., Mazzola, G. C., Malagoli, A., Falutz, J., Cervo, A., Petta, S., Pembroke, T., Ghali, P., Besutti, G., et al. (2019) · HIV Medicine · doi:10.1111/hiv.12799 · Cited by 15

Liver Stiffness Rises Early in MASLD and Drives Inflammation, Lipid Dysmetabolism, and Fibrosis via Piezo1–YAP Mechanotransduction

Ma, J., Xie, N., Wang, Z., Liang, X., Han, Y., Zhao, Q., Wang, M., Lu, H., Kou, W., Alazawi, W., et al. (2026) · Advanced Science · doi:10.1002/advs.202519109 · Cited by 14

The Association Between Metabolic Dysfunction‐Associated Steatotic Liver Disease and Change in Liver Stiffness in Patients With Chronic Hepatitis B

Patmore, L. A., van Eekhout, K. M. A., Koc, Ö. M., de Knegt, R. J., Janssen, H. L. A., Brouwer, W. P., Kramer, M., Honkoop, P., de Bruijne, J., Boland, G. J., et al. (2025) · Liver International · doi:10.1111/liv.70042 · Cited by 14

Liver-spleen axis: Deciphering a crucial crosstalk in non-alcoholic fatty liver disease progression and therapeutic implications

Tarantino, G., & Citro, V. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.119467 · Cited by 14

Prevalence of Hepatic Steatosis and Fibrosis in the United States

Choi, Y. S., Beltran, T., Calder, S. A., Padilla, C. R., Berry-Cabán, C. S., & Salyer, K. R. (2021) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2021.0111 · Cited by 14

Non-invasive assessment of metabolic dysfunction–associated fatty liver disease

Kumar, C. V. C., Skantha, R., & Chan, W. (2022) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188221139614 · Cited by 14

Association between composite dietary antioxidant index and metabolic dysfunction associated steatotic liver disease: result from NHANES, 2017-2020

Zhang, Z., Wang, H., & Chen, Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1412516 · Cited by 14

Association of sleep patterns and disorders with metabolic dysfunction-associated steatotic liver disease and liver fibrosis in contemporary American adults

Zong, G., Mao, W., Wen, M., Cheng, X., & Liu, G. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2024.101583 · Cited by 14

Marcadores de fibrosis hepática

Caballería, L., Torán‐Monserrat, P., & Caballería, J. (2017) · Medicina Clínica · doi:10.1016/j.medcli.2017.08.009 · Cited by 14

Semi-Quantitative Ultrasonographic Evaluation of NAFLD

Ballestri, S., Tana, C., Girolamo, M. D., Fontana, M. C., Capitelli, M., Lonardo, A., & Cioni, G. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200417142444 · Cited by 14

Interplay between Heart Disease and Metabolic Steatosis: A Contemporary Perspective

Ramadan, M. S., Russo, V., Nigro, G., Durante‐Mangoni, E., & Zampino, R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081569 · Cited by 15

The Prevalence of Liver Steatosis and Fibrosis Assessed by Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter in Apparently Healthy Romanian Medical Students

Năstasă, R., Stanciu, C., Zenovia, S., Sîngeap, A.-M., Cojocariu, C., Sfarti, C. V., Gîrleanu, I., Chiriac, S. A., Cuciureanu, T., Huiban, L., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11122341 · Cited by 14

The Non-Invasive Ultrasound-Based Assessment of Liver Viscosity in a Healthy Cohort

Popa, A., Sporea, I., Bende, F., Popescu, A., Fofiu, R., Borlea, A., Bâldea, V., Pascu, A., Foncea, C. G., Cotrău, R., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12061451 · Cited by 16

Controlled attenuation parameter accurately detects liver steatosis in people with HIV

Duarte, M., Tien, P. C., Ma, Y., Noworolski, S. M., Korn, N. J., & Price, J. C. (2022) · AIDS · doi:10.1097/qad.0000000000003351 · Cited by 14

Metabolic Dysfunction-Associated Fatty Liver Disease in the National Health and Nutrition Examination Survey 2017–2020: Epidemiology, Clinical Correlates, and the Role of Diagnostic Scores

Theofilis, P., Vordoni, A., & Kalaitzidis, R. (2022) · Metabolites · doi:10.3390/metabo12111070 · Cited by 14

Lysosomal Acid Lipase: Can it be a New Non-Invasive Serum Biomarker of Cryptogenic Liver Fibrosis and Cirrhosis?

Gravito‐Soares, M., Gravito‐Soares, E., Gomes, D. L. F., & Tomé, L. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0012.7865 · Cited by 14

Biopsy rate and nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD)

Gerhardt, F., Petroff, D., Blank, V., Böhlig, A., van Bömmel, F., Wittekind, C., Berg, T., Karlas, T., & Wiegand, J. (2020) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2020.1766554 · Cited by 14

Diagnostic Performance of Ultrasound‐Based Liver Fat Quantification With Reference to Magnetic Resonance Imaging Proton Density Fat Fraction and Histology

Dağ, N., Sarıcı, B., Igci, G., Yağın, F. H., Yılmaz, S., & Kutlu, R. (2025) · Journal of Clinical Ultrasound · doi:10.1002/jcu.24010 · Cited by 13

M probe comes first: Impact of initial probe choice on diagnostic performance of vibration controlled transient elastography

Blank, V., Petroff, D., Wiegand, J., & Karlas, T. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.08.003 · Cited by 13

New predictive models and indices for screening MAFLD in school-aged overweight/obese children

Xing, Y., Zhang, P., Li, X., Jin, S., Xu, M., Jia, J., Wang, H., Li, L., & Wang, H. (2023) · European Journal of Pediatrics · doi:10.1007/s00431-023-05175-x · Cited by 13

Association between dietary intakes of B vitamins and nonalcoholic fatty liver disease in postmenopausal women: a cross-sectional study

Li, J., Huang, J., Lv, Y., & Ji, H. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1272321 · Cited by 13

Association between different obesity patterns and the risk of NAFLD detected by transient elastography: a cross-sectional study

Sun, J., Yan, C., Wen, J., Wang, F., Wu, H., & Xu, F. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03303-x · Cited by 13

Accuracy of Controlled Attenuation Parameter for Liver Steatosis in High-Risk Patients for MASLD Using MRI-Proton Density Fat Fraction as Reference Standard

Malandris, K., Korakas, E., Sarakapina, A., Kalopitas, G., Iatridi, F., Liakos, A., Bekiari, E., Γιουλεμέ, Ό., Tzatzagou, G., Karagiannis, T., et al. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-024-08799-7 · Cited by 13

Influence of Probe Pressure on Ultrasound-Based Shear Wave Elastography of the Liver Using Comb-Push 2-D Technology

Byenfeldt, M., Elvin, A., & Fransson, P. (2018) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2018.09.023 · Cited by 13

Serum levels of soluble dipeptidyl peptidase-4 in type 2 diabetes are associated with severity of liver fibrosis evaluated by transient elastography (FibroScan) and the FAST (FibroScan-AST) score, a novel index of non-alcoholic steatohepatitis with significant fibrosis

Sagara, M., Iijima, T., Kase, M., Kato, K., Sakurai, S., Tomaru, T., Jojima, T., Usui, I., & Aso, Y. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107885 · Cited by 13

Independent associations of thyroid-related hormones with hepatic steatosis and insulin resistance in euthyroid overweight/obese Chinese adults

Ma, D., Zeng, J., Huang, B., Yan, F., Ye, J., Chen, Y., Zeng, X., Zheng, X. S., Xiao, F., Lin, M., et al. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-02011-0 · Cited by 13

Ultrasound and FibroScan® Controlled Attenuation Parameter in patients with MAFLD: head to head comparison in assessing liver steatosis

Salmi, A., di Filippo, L., Ferrari, C., Frara, S., & Giustina, A. (2022) · Endocrine · doi:10.1007/s12020-022-03157-x · Cited by 14

Associations of serum folate and vitamin C levels with metabolic dysfunction-associated fatty liver disease in US adults: A nationwide cross-sectional study

Jiang, Y., Cao, H., Chen, X., Yu, G., Song, C., Duan, H., Tian, F., Wan, H., & Shen, J. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1022928 · Cited by 13

Non-alcoholic fatty liver and fibrosis is associated with cardiovascular structure and function in young adults

Tang, R., Abeysekera, K. W. M., Howe, L. D., Hughes, A. D., & Fraser, A. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000087 · Cited by 13

Evaluation of 2-year outcomes in infants born to mothers with and without NAFLD in pregnancy

Gross, A. S., Lange, M., Rosenbluth, E., Carroll, C., SPERLING, R. S., Juliano, C. E., Sigel, K. M., Friedman, S. L., Argiriadi, P. A., Chu, J., et al. (2023) · European Journal of Pediatrics · doi:10.1007/s00431-023-05044-7 · Cited by 18

The correlation of controlled attenuation parameter results with ultrasound-identified steatosis in real-world clinical practice

Yen, Y., Chen, J., Wu, C., Lin, M., Chang, K., Tseng, P., Tsai, M., Lin, J.-T., & Hu, T. (2017) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2017.08.010 · Cited by 13

Controlled attenuation parameter in NAFLD identifies risk of suboptimal glycaemic and metabolic control

Patel, P. J., Hossain, F., Horsfall, L. U., Banh, X., Hayward, K. L., Williams, S., Johnson, T., Brown, N. N., Saad, N., Valery, P. C., et al. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.05.008 · Cited by 13

Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART

Dold, L., Nielsen, M. J., Praktiknjo, M., Schwarze‐Zander, C., Boesecke, C., Schierwagen, R., Mohr, R. U., Wasmuth, J., Jansen, C., Bischoff, J., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219526 · Cited by 13

Association of sex hormones with hepatic steatosis in men with chronic hepatitis B

Chen, Q., Zhao, L., Mei, L., Zhong, R., Han, P., Yang, H., Li, Q., & Li, J. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.05.022 · Cited by 13

Early screening for chronic liver disease: impact of a FIB-4 first integrated care pathway to identify patients with significant fibrosis

Mignot, V., Chirica, C., Tron, L., Borowik, A., Borel, A., Rostaing, L. P. E., Bouillet, L., Decaens, T., Guergour, D., & Costentin, C. E. (2024) · Scientific Reports · doi:10.1038/s41598-024-66210-x · Cited by 12

Metabolic dysfunction‐associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi‐centre cross‐sectional study

Vergani, M., Borella, N. D., Rizzo, M., Conti, M., Perra, S., Bianconi, E., Sani, E., Csermely, A., Grespan, E., Targher, G., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16333 · Cited by 12

Is There a Diagnostic Miracle on the Horizon? Emerging Biomarkers in MASLD

Iwaszko-Sochal, K., Kasztelan‐Szczerbińska, B., & Cichoż‐Lach, H. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14176148 · Cited by 13

Identification of High-Risk Patients With Nonalcoholic Fatty Liver Disease in Endocrinology Clinics

Younossi, Z. M., Henry, L. L., Isaacs, S. D., & Cusi, K. J. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.06.012 · Cited by 14

Hepatic steatosis using ultrasound-derived fat fraction: First technical and clinical evaluation

Huang, Y., Cheng, J., Wang, Y., Xu, X., Wang, S., Li, W., & Dong, Y. (2023) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-238102 · Cited by 12

Alpha-1 Antitrypsin Augmentation and the Liver Phenotype of Adults With Alpha-1 Antitrypsin Deficiency (Genotype Pi∗ZZ)

Fromme, M., Hamesch, K., Schneider, C. V., Mandorfer, M., Pons, M., Thorhauge, K. H., Pereira, V. M., Šperl, J., Fraňková, S., Reichert, M., et al. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.08.038 · Cited by 12

A prospective comparison of three ultrasound-based techniques in quantitative diagnosis of hepatic steatosis in NAFLD

Zhu, Y., Yin, H., Zhou, D., Zhao, Q., Wang, K., Fan, Y., Chen, K., Han, H., & Xu, H. (2023) · Abdominal Radiology · doi:10.1007/s00261-023-04078-7 · Cited by 12

Predictors of controlled attenuation parameter in metabolic dysfunction

Bianco, C., Pelusi, S., Margarita, S., Tavaglione, F., Jamialahmadi, O., Malvestiti, F., Periti, G., Rondena, J., Tomasi, M., Carpani, R., et al. (2023) · United European Gastroenterology Journal · doi:10.1002/ueg2.12513 · Cited by 11

Visceral and subcutaneous abdominal fat is associated with non-alcoholic fatty liver disease while augmenting Metabolic Syndrome’s effect on non-alcoholic fatty liver disease: A cross-sectional study of NHANES 2017–2018

Elguezabal-Rodelo, R. G., Porchia, L. M., Torres‐Rasgado, E., López‐Bayghen, E., & González-Mejía, M. E. (2024) · PLoS ONE · doi:10.1371/journal.pone.0298662 · Cited by 12

Nanoformulations for the diagnosis and treatment of metabolic dysfunction-associated steatohepatitis

Qin, X., & Liu, J. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.06.014 · Cited by 13

Serum uric acid as a biomarker for metabolic dysfunction-associated steatotic liver disease: insights from ultrasound elastography in a Chinese cohort

Chang, Z., & Liu, Z. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03666-9 · Cited by 12

Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral‐Induced Cure of Hepatitis C Virus Infection

Chang, Y., Lee, J., Chen, C.-Y., Kao, W., Lin, C., Yang, S., Shih, Y., Peng, C., Lee, F., Tsai, M., et al. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70029 · Cited by 12

Assessment of the diagnostic efficacy of five non-invasive tests for MASLD: external validation utilizing data from two cohorts

Zou, H., Wen, P., & Sun, X. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1571487 · Cited by 12

Detection of pediatric hepatic steatosis through ultrasound backscattering analysis

Chuang, Y.-H., Hsieh, C.-S., Lai, M., Chen, C.-C., Chao, H., Yeh, H.-Y., Lai, H.-H., & Tsui, P. (2020) · European Radiology · doi:10.1007/s00330-020-07391-7 · Cited by 12

Relationship between Dietary Fatty Acid Intake with Nonalcoholic Fatty Liver Disease and Liver Fibrosis in People with HIV

de Almeida, C. F., da Silva, P. S., Cardoso, C. S. D. A., Gorni, N., Cormack, J. A., de Andrade, M. M., Silva, J. D. S., Araújo, M. C., Peres, W. A. F., do Brasil, P. E. A. A., et al. (2021) · Nutrients · doi:10.3390/nu13103462 · Cited by 12

New frontiers in liver ultrasound: From mono to multi parametricity

Bartolotta, T. V., Taibbi, A., Randazzo, A., & Gagliardo, C. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i10.1302 · Cited by 12

Liver steatosis and metabolic dysfunction-associated fatty liver disease among HIV-positive and negative adults in urban Zambia

Chihota, B., Riebensahm, C., Muula, G. K., Sinkala, E., Chilengi, R., Mulenga, L., Bosomprah, S., Vinikoor, M. J., Bolton‐Moore, C., Egger, M., et al. (2022) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2022-000945 · Cited by 12

Prevalence of fatty liver and advanced fibrosis by ultrasonography and FibroScan in a general population random sample

Nagaoki, Y., Sugiyama, A., Mino, M., Kodama, H., Abe, K., Imada, H., Ouoba, S., Bunthen, E., Ko, K., Akita, T., et al. (2022) · Hepatology Research · doi:10.1111/hepr.13821 · Cited by 12

Liver steatosis and fibrosis in people with human immunodeficiency virus in West Africa and the relationship with hepatitis B virus coinfection

Villa, G. C. F., Owusu, D., Smith, C. J., Azumah, M., Abdullahi, A., Phillips, S., Sayeed, L., Austin, H., Chadwick, D., Phillips, R. O., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.2000 · Cited by 12

Ultrasound-Based Hepatic Elastography in Non-Alcoholic Fatty Liver Disease: Focus on Patients with Type 2 Diabetes

Cazac, G.-D., Lăcătușu, C.-M., Mihai, C., Grigorescu, E.-D., Onofriescu, A., & Mihai, B. M. (2022) · Biomedicines · doi:10.3390/biomedicines10102375 · Cited by 14

Genetic variants associated with circulating liver injury markers in Mexican Americans, a population at risk for non-alcoholic fatty liver disease

Sabotta, C. M., Kwan, S., Petty, L. E., Below, J. E., Joon, A. Y., Wei, P., Fisher‐Hoch, S. P., McCormick, J. B., & Beretta, L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.995488 · Cited by 12

Visceral Obesity and Cytokeratin-18 Antigens as Early Biomarkers of Liver Damage

de Alteriis, G., Pugliese, G., Sarno, A. D., Muscogiuri, G., Barrea, L., Cossiga, V., Perruolo, G., Tolla, M. F. D., Zumbolo, F., Formisano, P., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310885 · Cited by 12

Volumetric Liver Fat Fraction Determines Grade of Steatosis More Accurately Than Controlled Attenuation Parameter in Patients With Nonalcoholic Fatty Liver Disease

Harry, S., Lai, L. L., Mustapha, N. R. N., Aziz, Y. F. A., Vijayananthan, A., Rahmat, K., Mahadeva, S., & Chan, W. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.08.023 · Cited by 12

A Spatially Weighted Regularization Method for Attenuation Coefficient Estimation

Deeba, F., Hu, R., Terry, J., Pugash, D., Hutcheon, J. A., Mayer, C., Salcudean, S. E., & Rohling, R. N. (2019) · IEEE International Ultrasonics Symposium · doi:10.1109/ultsym.2019.8925604 · Cited by 12

Portal venous and hepatic artery hemodynamic variation in non-alcoholic fatty liver disease

Sabry, M., Youssef, T. M., Shaker, M. K., Salama, M. M., Aly, N. A., & Anwar, C. A. (2021) · Egyptian Liver Journal · doi:10.1186/s43066-021-00130-7 · Cited by 12

No influence of hepatic steatosis on the 3‐year outcomes of patients with quiescent chronic hepatitis B

Chang, J. W., Lee, J. S., Lee, H. W., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., & Kim, S. U. (2021) · Journal of Viral Hepatitis · doi:10.1111/jvh.13594 · Cited by 12

Hepatitis C cure improved patient‐reported outcomes in patients with and without liver fibrosis in a prospective study at a large urban medical center

Sung, J. C., Bosh, C., Wyatt, B. E., Miller, M., Harty, A., Bello, D. D., Knight, S., Dieterich, D. T., Perumalswami, P., & Branch, A. D. (2019) · Journal of Viral Hepatitis · doi:10.1111/jvh.13234 · Cited by 12

Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients

Shen, F. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i16.4702 · Cited by 107

Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience

Baumeler, S., Jochum, W., Neuweiler, J., Bergamin, I., & Semela, D. (2019) · Swiss Medical Weekly · doi:10.4414/smw.2019.20077 · Cited by 19

[A multi-center clinical study of a novel controlled attenuation parameter for assessment of fatty liver].

Shen, F., Zheng, R., Mi, Y., Shi, J., Chen, G., Chen, J., Xu, L., Pan, Q., Xu, L., & Fan, J. (2014) · PubMed · doi:10.3760/cma.j.issn.1007-3418.2014.12.010 · Cited by 4

Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis

Pu, K., Wang, Y., Bai, S., Wei, H., Zhou, Y., Fan, J., & Qiao, L. (2019) · BMC Gastroenterology · doi:10.1186/s12876-019-0961-9 · Cited by 197

Controlled attenuation parameter ( CAP ) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population

Chon, Y. E., Jung, K. S., Kim, S. U., Park, J. Y., Park, Y. N., Kim, D. Y., Ahn, S. H., Chon, C. Y., Lee, H. W., Park, Y., et al. (2013) · Liver International · doi:10.1111/liv.12282 · Cited by 167